Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Merger or Acquisition (June 2025)
18 slides from Apollo Hospitals Enterprise's merger presentation, Jun 30, 2025
Slide 1: Regulation 30 disclosure cover letter
=N /) APOLLO HOSPITALS ENTERPRISE LIMITED llo CIN : L85110TN1979PLC008035 OSPITALS June 30, 2025 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, Sth Floor Dalal Street, Plot No.C/1, ‘G’ Block Mumbai - 400 001. Bandra
Slide 2: Apollo Healthco Ltd: Composite Scheme of Arrangement
Apollo Healthco Ltd India’s Largest Omnichannel pharmacy distribution and Digital health platform Composite Scheme of Arrangement June 30, 2025
Slide 3: Disclaimer
® © Disclaimer 2 e The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentatio
Slide 4: Executive Summary
Executive Summary Announced an INR 2,475 Cr (US $300mn) investment from Advent in April 2024 and our intent to consolidate Keimed (in stages) into Apollo HealthCo Ltd (AHL). Obtained Board approval and subsequent shareholder approval Transaction in August 2024 for Advent Investment and Keimed merger
Slide 5: Executive Summary (2/2)
Executive Summary (2/2) | | « Allregulatory and other approvals as necessary for the proposed structure would be obtained over the next few | Approval i months process and |+ Independent valuation conducted by KPMG (BSR) and BDO, and fairness opinion provided by Axis Capital Governance | | - Shareho
Slide 6: Proposed Scheme - Process
Proposed Scheme - Process D} e —————— Proposes to undertake below transactions sequentially, via a scheme of arrangement, subject to requisite corporate and regulatory approvals Demerger of Omnichannel pharmacy distribution (OCP) and Apollo 24|7 digital platform Stepl (shares of AHEL in Apollo Healt
Slide 7: Composite scheme: Overview
o Composite scheme : Overview D} ———————————— ————— e ] Shareholder approved Resultant Group Structure Resultant Group Structure Proposed Now in August 2024 (Post all approvals) * Automatic listing of New Co - Direct participation of AHEL shareholders in New Co Keimed AHEL promoters : and Other SH |
Slide 8: Strategic Rationale for Proposed Structure (1/2)
Strategic Rationale for Proposed Structure (1/2) Creates India’s largest listed Omni channel Pharmacy (OCP) distribution and Digital health platform with a scale of INR ~ 25k Cr (~US$3 bn) in Revenues by end FY27 Enables AHEL shareholders to gain direct shareholding to India’s largest omni channel P
Slide 9: Strategic Rationale for Proposed Structure (2/2)
S ® O Strategic Rationale for Proposed Structure (2/2) L] » AHEL will continue to hold ~ 15% of New co directly (17.5% including interest held through FHPL) - Establishes an independent, focused yet Integrated healthcare platform offering curated solutions, spanning across entire patient journey. -
Slide 10: India's largest Omnichannel Pharmacy and Digital Health powerhouse
o India’s largest Omnichannel Pharmacy and Digital Health powerhouse... 2i FY25 Key Operational Metrics \ ~US$2 bn 150mn+ ~65mn+ Scale Proforma Combined Revenue Life time customers Annual customers Largest omni channel healthcare company Industry leading customer life time value /‘ 6,626 75k+ 3k+ 19
Slide 11: With deep Offline and Online presence
o cesseseeses.With deep Offline and Online presence D} Offline Pharmacy Distributio Apollo 24|7 A full-suite digital platform with a one-stop India’s largest Organized Pharmacy Platform with integrated access covering entire patient journey presence in ~1,200 cities/ towns spread across 22 States an
Slide 12: Keimed | India's Largest Pharma Distributor
® ©® Keimed | India’s Largest Pharma Distributor ———————————— ————— e ] i Keimed has >2x the scale of its nearest competitor in a highly fragmented industry with 70,000+ distributors Unmatched Trusted High Quality Preferred Sales State-of-the-art Experienced Scale and Manufacturer Customer Base Part
Slide 13: Combined Financial Metrics Snapshot
) Combined Financial Metrics | Snapshot i FY25 figures in INR Cr . Online + ) Offline Telehealth AHL Keimed?23 NewCo* GMV: 3,077 GMV: 11,091 GMV: 18,196 8,01 Revenue: 1,149 Revenue: 9,163 (2558 Revenue: 16,267 u PEthI;I;\Ec)iAAs 612 143 756 406 1,155 Margin % 7.6% 12.5% 8.2% 3.2% 7.1% 24/7 operatin:
Slide 14: Balance Sheet position - Mar'25
@ © Balance Sheet position — Mar’25 | Stronger post the transaction 1 ~ Keimes ew € Net Worth 2,3214 1,143 3,425 Net Debt / (Cash) 383 1,551 1,934 Other liabilities 200 82 283 Sources of Funds 2,904 2,776 5,642 Net Working Capital 1,628 2,296 3,925 Other assets 1,276 479 1,M7 Application of Funds 2,
Slide 15: Merged Entity | Financial Outlook (Proforma)
® ® Merged Entity | Financial Outlook (Proforma) i i FY27 Exit : FY25 : Run-rate Target : Target to achieve EBITDA breakeven for digital business in next 4 quarters Revenue GMV: 18,196 Cr GMV: ~28,000Cr Revenue:16267Cr : Revenue: ~25,000 Cr Proposed integration to enable higher H i margin realisatio
Slide 16: Transaction Advisors
® S o Transaction Advisors ————— i Financial advisors - VedaCorp Legal advisors for the scheme - Shardul Amarchand Mangaldas & Co (SAM) Fairness Opinion provided by Axis Capital Independent valuation conducted by KPMG (BSR) and BDO
Slide 17: Steps and Timelines
® © Steps and Timelines D} 1 Jut25 m@mfifim@ D || B Mmm Feb 27 ) Board meeting to approve the Scheme Submission of application @ with stock exchanges/SEBI Submission of [ ] application to CCland IRDAI @ NOC from stock exchanges/SEBI Approvals from CCI ® and IRDAI Submission of Scheme with NCLT Approva
Slide 18: Thank You.
Thank You.
Apollo Hospitals Enterprise — Merger or Acquisition (June 2025) on 6ix